BPA Call HT001415A0010-0010
Award Date 9/30/16
Potential Completion Date 9/30/17
Potential Value $3.3M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $27,445.00, is for the provision of micro reagents, kits, and consumables. It has a period of performance through May 20, 2025. The contract is not designated as a set-aside. Roche Diagnostics holds...
- The U.S. Defense Health Agency awarded Roche Diagnostics Corporation a Blanket Purchase Agreement (BPA) call valued at $2,515,000.00 for the provision of reagents and consumables. This is not a set-aside contract. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies, including the Department of Veterans Affairs, Department of...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for REAGENTS AND SUPPLIES with a ceiling value of $59,787.69 and an ultimate completion date of September 30, 2019. This BPA call is part of a larger $37 million BPA with DHA for immunochemistry and clinical...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $302,000.00, is a Blanket Purchase Agreement (BPA) Call placed by the Defense Health Agency (DHA) for the procurement of REAGENTS AND CONSUMABLES. This BPA is part of a larger Indefinite Delivery Contract vehicle held by Roche Diagnostics to provide chemistry reagents...
- This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation for reagents and consumables for medical laboratory testing. The BPA is against VA Schedule Contract #V797P-7347A, which enables DHA to efficiently acquire Roche's diagnostic technologies through pre-negotiated pricing and terms. The contract has a ceiling value of $354,198.51 and a period of performance through May 2, 2025. No set-aside designation was used for this award....
- This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $2,800,000.00 Blanket Purchase Agreement (BPA) Call contract is for the provision of reagents and peripheral consumables. The contract is not designated as a set-aside. Roche Diagnostics holds multiple Indefinite Delivery Vehicles (IDVs) and BPAs with federal agencies such as...
- This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $379,486.57, is against VA Schedule #V797P-7347A for Reagents and Consumables and has a period of performance through September 24, 2024. No set-aside designation was used. Roche Diagnostics has provided critical care analyzers,...
- The Defense Health Agency has awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostic products and laboratory equipment, for the provision of reagents and consumables. This contract is a child award under the VA Schedule V797P-7347A and carries a ceiling value of $288,642.16 under firm fixed-price terms. The award was made on April 30, 2025, with an ultimate completion date of May 2, 2025, and no set-aside designation was...
- This is a firm fixed-price blanket purchase agreement (BPA) call awarded by the Defense Health Agency to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of reagents and peripheral consumables supplies and services, such as prep kits, test tubes, and amplification kits, to be provided at the request of the customer. The potential value of the contract...
- This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents and consumables. The BPA, valued at $344,741.86, was established against Roche's existing General Services Administration (GSA) Schedule contract for critical laboratory analyzers and supplies. The BPA allows DHA facilities to purchase essential medical equipment and consumables through pre-negotiated pricing and terms with...